Rick Kent

Date:
31 Jan 2002
Reference:
WF/M/AV/O/03/46
Part of:
Wellcome Foundation Ltd
  • Archives and manuscripts

About this work

Description

The folder contains a copy of his transcript, also 1 audio tape. The interview refers to: * his work at the company from 1983 as a research physician; the merger of Glaxo-Wellcome; FDA meetings. * drugs - his work on Wellbrutin (esp. Zyban); trifenagrel; tissue plaminogen activator (TPA); AZT.

Publication/Creation

31 Jan 2002

Physical description

2 items

Terms of use

This item is restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2053.

Languages

Where to find it

  • LocationStatusAccess
    Closed stores

Permanent link